# Noumed Pharmaceuticals to build $85M drug manufacturing facility in Adelaide

Noumed Pharmaceuticals, part of UK company Noumed Life Sciences, will build an $85 million drug manufacturing facility at Salisbury South in northern Adelaide, with a $20 million grant from the federal government's Modern Manufacturing Initiative. The facility will create 180 ongoing jobs and produce around 40 million units of tablets, creams, and liquids when it opens in 2025.

- Type: New facility
- Announced: 2021-07-08
- Where: Salisbury South, Adelaide, Australia
- Value: $63.0M (85.0M AUD)
- Jobs: 180
- Starts operating: 2025
- Status: announced
- Capacity: 40 million units per year
- Products: tablets, creams, liquids

## Companies

- [Noumed Pharmaceuticals](https://endata.com/companies/56335.md)
- [Noumed Life Sciences](https://endata.com/companies/56336.md) (investor)

## Sources

- [innovationaus.com](https://www.innovationaus.com/mmi-grant-brings-global-pharma-firm-to-adelaide/), 2021-07-08: "Noumed Pharmaceuticals, part of UK company Noumed Life Sciences, on Thursday revealed plans to build an $85 million facility at Salisbury South"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.